Search Results

Filter
  • 1-10 of  214 results for ""Antibodies, Antineutrophil Cytoplasmic""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Antineutrophil cytoplasmic antibody positivity incidence before and during COVID-19 pandemic.

  • Authors : Dijana P; Division of Rheumatology and Clinical Immunology, Department of Internal medicine, University hospital of Split, Šoltanska 1, Split, Croatia.; Department of Internal Medicine, School of Medicine, University of Split, Šoltanska 2, Split, Croatia.

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/immunology ; Antibodies, Antineutrophil Cytoplasmic*/Antibodies, Antineutrophil Cytoplasmic*/Antibodies, Antineutrophil Cytoplasmic*/blood

  • Source: Rheumatology international [Rheumatol Int] 2024 Oct; Vol. 44 (10), pp. 1935-1940. Date of Electronic Publication: 2024 Apr 24.Publisher: Springer International Country of Publication: Germany NLM ID: 8206885 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A Transient Increase in the Serum ANCAs in Patients with SARS-CoV-2 Infection: A Signal of Subclinical Vasculitis or an Epiphenomenon with No Clinical Manifestations? A Pilot Study.

  • Authors : Gelzo M; CEINGE-Biotecnologie Avanzate, Scarl, 80145 Naples, Italy.; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.

Subjects: SARS-CoV-2*; Antibodies, Antineutrophil Cytoplasmic/Antibodies, Antineutrophil Cytoplasmic/Antibodies, Antineutrophil Cytoplasmic/*blood ; COVID-19/COVID-19/COVID-19/*blood

  • Source: Viruses [Viruses] 2021 Aug 29; Vol. 13 (9). Date of Electronic Publication: 2021 Aug 29.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

×
Academic Journal

[ANCA-Associated Glomerulonephritis Following SARS-CoV2 Infection: A Case Report].

  • Authors : Maiorca C; UOC Pronto Soccorso e Medicina d'Urgenza, P.O. San Filippo Neri, ASL Roma 1, Roma.; Serriello I

Subjects: COVID-19*/COVID-19*/COVID-19*/complications ; COVID-19*/COVID-19*/COVID-19*/immunology ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/complications

  • Source: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia [G Ital Nefrol] 2024 Oct 31; Vol. 41 (5). Date of Electronic Publication: 2024 Oct 31.Publisher: Società Italiana di Nefrologia Country of Publication: Italy NLM ID: 9426434 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

COVID-19-induced granulomatosis with polyangiitis: A case report of a 16-year-old East Asian and literature review.

  • Authors : Jiang R; Department of Respiratory and Critical Care Medicine, Changsha Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.; Zhou H

Subjects: COVID-19*/COVID-19*/COVID-19*/complications ; Granulomatosis with Polyangiitis*/Granulomatosis with Polyangiitis*/Granulomatosis with Polyangiitis*/diagnosis ; Granulomatosis with Polyangiitis*/Granulomatosis with Polyangiitis*/Granulomatosis with Polyangiitis*/complications

  • Source: Immunity, inflammation and disease [Immun Inflamm Dis] 2024 Sep; Vol. 12 (9), pp. e70010.Publisher: John Wiley and Sons Ltd Country of Publication: England NLM ID: 101635460 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial.

  • Authors : Zonozi R; Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Boston, Massachusetts, USA .; Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Subjects: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/drug therapy ; COVID-19*; Humans

  • Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Feb 15; Vol. 83 (3), pp. 351-359. Date of Electronic Publication: 2024 Feb 15.Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic)

Record details

×
Academic Journal

Birmingham vasculitis activity score and the short form 36-item health survey predict current depressive disorders in patients with antineutrophil cytoplasmic antibody-associated vasculitis during the SARS-CoV-2 pandemic.

  • Authors : Yun JD; Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, 03722, Seodaemun-gu, Seoul, Korea (Republic of).; Lee JH

Subjects: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/diagnosis ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/epidemiology

  • Source: Zeitschrift fur Rheumatologie [Z Rheumatol] 2024 Feb; Vol. 83 (Suppl 1), pp. 222-229. Date of Electronic Publication: 2022 Jun 24.Publisher: Springer Country of Publication: Germany NLM ID: 0414162 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-1250

Record details

×
Academic Journal

A case of rapidly progressive glomerulonephritis with double-positive anti-GBM antibody and MPO-ANCA after SARS-CoV-2 vaccination and relapse during 1 year follow-up.

  • Authors : Terakawa K; Department of Nephrology, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjyuku-Ku, Tokyo, Japan.; Niikura T

Subjects: Glomerulonephritis* ; COVID-19*/COVID-19*/COVID-19*/complications ; Nephritis*/Nephritis*/Nephritis*/complications

  • Source: CEN case reports [CEN Case Rep] 2024 Feb; Vol. 13 (1), pp. 19-25. Date of Electronic Publication: 2023 Apr 27.Publisher: Springer Japan Country of Publication: Japan NLM ID: 101636244 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Review

ANCA-associated glomerulonephritis and lupus nephritis following COVID-19 vaccination: a case report and literature review.

  • Authors : Campos MAG; Clinical Hospital of State University Júlio de Mesquita Filho, State University of São Paulo, Botucatu, São Paulo, Brazil.; Valois TO

Subjects: Lupus Nephritis*/Lupus Nephritis*/Lupus Nephritis*/etiology ; COVID-19* ; Glomerulonephritis*/Glomerulonephritis*/Glomerulonephritis*/etiology

  • Source: Frontiers in immunology [Front Immunol] 2024 Jan 08; Vol. 14, pp. 1298622. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2023).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

SARS-CoV-2 infection associated with antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (ANCA-GN): a systematic review and two case reports.

Subjects: COVID-19*/COVID-19*/COVID-19*/complications ; COVID-19*/COVID-19*/COVID-19*/diagnosis ; Glomerulonephritis*/Glomerulonephritis*/Glomerulonephritis*/diagnosis

  • Source: Journal of nephrology [J Nephrol] 2024 Jan; Vol. 37 (1), pp. 53-63. Date of Electronic Publication: 2023 Nov 06.Publisher: Springer Country of Publication: Italy NLM ID: 9012268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1724-6059

Record details

×
Report

De Novo ANCA-Negative Pauci-Immune Crescentic Glomerulonephritis After COVID-19 mRNA Vaccination: A Case Report.

  • Authors : Cho H; Division of Nephrology, Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea.; Lee HS

Subjects: COVID-19* ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; Glomerulonephritis*/Glomerulonephritis*/Glomerulonephritis*/drug therapy

  • Source: Journal of Korean medical science [J Korean Med Sci] 2023 Oct 23; Vol. 38 (41), pp. e341. Date of Electronic Publication: 2023 Oct 23.Publisher: Korean Academy of Medical Science Country of Publication: Korea (South) NLM ID: 8703518 Publication Model: Electronic Cited Medium: Internet

Record details

×
  • 1-10 of  214 results for ""Antibodies, Antineutrophil Cytoplasmic""